Ilomastat is primarily used in research settings as a potent inhibitor of matrix metalloproteinases (MMPs), which are enzymes involved in the breakdown of extracellular matrix components. Its application is significant in studying processes like tissue remodeling, wound healing, and cancer metastasis, where MMP activity plays a critical role. By inhibiting these enzymes, ilomastat helps researchers understand the mechanisms underlying these processes and explore potential therapeutic interventions. Additionally, it is utilized in in vitro studies to prevent the degradation of extracellular matrix proteins, ensuring the integrity of cell cultures and experimental models. Its role in modulating MMP activity also makes it valuable in investigating inflammatory diseases and other conditions linked to excessive matrix degradation.